Literature DB >> 32143838

NK cells prevent T cell lymphoma development in T cell receptor-transgenic mice.

Sigrid Dubois1, Lionel Feigenbaum2, Thomas A Waldmann1, Jürgen R Müller3.   

Abstract

Mice that express a single transgenic T cell receptor have a low incidence of T cell lymphoma development. We investigated whether this tumor development is restricted by surveillance mechanisms that are exerted by IL-15-dependent cells. Lymphoma incidence was increased to between 30 and 60% when TCR transgenes were expressed in IL-15-deficient mice. Mice in which NK cells had been depleted genetically or with neutralizing antibodies allowed lymphoma growth while the absence of CD8 T cells was without consequence. Half of the emerged T cell lymphomas carried Notch1 mutations. The distinct phenotype of the lymphomas involved expression of PD1, CD30, CD24, the stress receptor ligand Mult1 and MHC class I down-regulation. NK cells were able to directly lyse lymphoma cells, and neutralizations of Mult1 and class I expression prevented NK cell degranulation. Together these data support an involvement of NK cells in tumor surveillance of nascent T cell lymphomas. Crown
Copyright © 2020. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cytotoxicity; NK cells; T cell lymphomas; TCR transgene; Tumor surveillance

Mesh:

Substances:

Year:  2020        PMID: 32143838      PMCID: PMC7217732          DOI: 10.1016/j.cellimm.2020.104081

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  36 in total

Review 1.  Qa-1, a nonclassical class I histocompatibility molecule with roles in innate and adaptive immunity.

Authors:  Peter E Jensen; Barbara A Sullivan; Lisa M Reed-Loisel; Dominique A Weber
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

2.  T-cell receptor diversity prevents T-cell lymphoma development.

Authors:  S Newrzela; N Al-Ghaili; T Heinrich; M Petkova; S Hartmann; B Rengstl; A Kumar; H-M Jäck; S Gerdes; I Roeder; M-L Hansmann; D von Laer
Journal:  Leukemia       Date:  2012-05-30       Impact factor: 11.528

Review 3.  Natural killer cell deficiency.

Authors:  Jordan S Orange
Journal:  J Allergy Clin Immunol       Date:  2013-09       Impact factor: 10.793

4.  Activating Notch1 mutations in mouse models of T-ALL.

Authors:  Jennifer O'Neil; Jennifer Calvo; Keith McKenna; Veena Krishnamoorthy; Jon C Aster; Craig H Bassing; Frederick W Alt; Michelle Kelliher; A Thomas Look
Journal:  Blood       Date:  2005-09-15       Impact factor: 22.113

5.  Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1-associated adult T-cell leukemia.

Authors:  Joanna Pancewicz; John M Taylor; Abhik Datta; Hicham H Baydoun; Thomas A Waldmann; Olivier Hermine; Christophe Nicot
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-07       Impact factor: 11.205

Review 6.  Immune escape mechanisms as a guide for cancer immunotherapy.

Authors:  Gregory L Beatty; Whitney L Gladney
Journal:  Clin Cancer Res       Date:  2014-12-12       Impact factor: 12.531

7.  Analysis of the T-cell receptor repertoire of human T-cell leukemia virus type 1 (HTLV-1) Tax-specific CD8+ cytotoxic T lymphocytes from patients with HTLV-1-associated disease: evidence for oligoclonal expansion.

Authors:  U Utz; D Banks; S Jacobson; W E Biddison
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

8.  Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice.

Authors:  M K Kennedy; M Glaccum; S N Brown; E A Butz; J L Viney; M Embers; N Matsuki; K Charrier; L Sedger; C R Willis; K Brasel; P J Morrissey; K Stocking; J C Schuh; S Joyce; J J Peschon
Journal:  J Exp Med       Date:  2000-03-06       Impact factor: 14.307

9.  T-cell repertoires in refractory coeliac disease.

Authors:  Julia Ritter; Karin Zimmermann; Korinna Jöhrens; Stefanie Mende; Anke Seegebarth; Britta Siegmund; Steffen Hennig; Kremena Todorova; Andreas Rosenwald; Severin Daum; Michael Hummel; Michael Schumann
Journal:  Gut       Date:  2017-02-10       Impact factor: 23.059

Review 10.  NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer Immunotherapy.

Authors:  Wei Wang; Amy K Erbe; Jacquelyn A Hank; Zachary S Morris; Paul M Sondel
Journal:  Front Immunol       Date:  2015-07-27       Impact factor: 7.561

View more
  1 in total

1.  Engagement of lymphoma T cell receptors causes accelerated growth and the secretion of an NK cell-inhibitory factor.

Authors:  Sigrid Dubois; Thomas A Waldmann; Jürgen R Müller
Journal:  Cell Immunol       Date:  2020-09-11       Impact factor: 4.868

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.